| Financial Year |
March 31 2023 |
| Monetary Funds |
551,523,770.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
8,828,614.84 |
| Accounts Receivable |
171,092,452.70 |
| Advances to Suppliers |
22,852,745.95 |
| Other Receivables |
8,256,562.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
95,210,577.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,638,089.55 |
| Total Current Assets |
862,873,231.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
51,144,599.83 |
| Under-construction Projects |
166,749,096.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,698,634.28 |
| R&D expenses |
-- |
| Goodwill |
458,608,480.15 |
| Long-Term Deferred and Prepaid Expenses |
8,993,468.56 |
| Deferred Income Tax Assets |
14,337,991.67 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,094,057,021.70 |
| Total Assets |
1,956,930,253.11 |
| Short-Term Loans |
80,090,138.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
72,365,614.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,005,442.23 |
| Taxes Payable |
4,447,497.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
34,378,393.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,188,122.70 |
| Other Current Liabilities |
4,164,099.53 |
| Sub-Total of Current Liabilities |
255,381,425.83 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
21,510,739.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
38,719,740.96 |
| Total Liabilities |
294,101,166.79 |
| Paid-In Capital(Or Share Stock) |
200,349,740.00 |
| Capital Surplus |
1,443,377,770.39 |
| Surplus Reserve |
43,881,252.93 |
| LESS:Treasury Stock |
17,721,600.00 |
| Undistributed Profits |
-19,756,861.02 |
| Minority Stockholder's Interest |
12,698,784.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,650,130,302.30 |
| Owner's Equity（Stockholder's Equity） |
1,662,829,086.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,956,930,253.11 |
